General Cannabis (OTCMKTS: CANN) and 111 (NASDAQ: YI) Head-To-Head Analysis


General Cannabis (OTCMKTS: CANN – Get Rating) and 111 (NASDAQ: YI – Get Rating) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk and profitability.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for General Cannabis and 111, as reported by MarketBeat.

Sell ​​Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
General Cannabis 0 0 0 0 ON
111 0 0 0 0 ON

Risk and Volatility

General Cannabis has a beta of 1.01, meaning that its stock price is 1% more volatile than the S&P 500. Comparatively, 111 has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500.

Valuation and Earnings

This table compares General Cannabis and 111’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price / Sales Ratio Net Income Earnings Per Share Price / Earnings Ratio
General Cannabis $ 5.93 million 4.34 – $ 8.87 million ON ON
111 $ 1.95 billion 0.07 – $ 84.18 million ($ 1.28) -1.37

General Cannabis has higher earnings, but lower revenue than 111.

Profitability

This table compares General Cannabis and 111’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
General Cannabis -149.64% -128.29% -46.38%
111 -5.38% -1,101.99% -21.16%

Insider and Institutional Ownership

4.7% of 111 shares are owned by institutional investors. 38.0% of General Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

General Cannabis beats 111 on 5 of the 9 factors compared between the two stocks.

General Cannabis Company Profile (Get Rating)

General Cannabis Corp. provides products and services to the regulated cannabis industry and non-cannabis customers in the United States. The company operates through Retail and Cultivation segments. It operates a licensed 17,000 square foot light deprivation greenhouse cultivation facility; and a retail dispensary store in Englewood, Colorado, as well as two retail stores in Portland, Oregon. The company was formerly known as Advanced Cannabis Solutions, Inc. and changed its name to General Cannabis Corp. in June 2015. General Cannabis Corp. was incorporated in 2013 and is headquartered in Denver, Colorado.

111 Company Profile (Get Rating)

111, Inc. operates an integrated online and offline platform in the healthcare market in the People’s Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2020, it operated 13 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Wuhan, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. 111, Inc. has strategic partnerships with Bayer Healthcare Co. Ltd .; BeiGene, Ltd .; Jianming Pharmaceutical Group; and Chugai Pharma China Co., Ltd. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People’s Republic of China.



Receive News & Ratings for General Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for General Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.

.

Leave a Reply

Your email address will not be published.

Back to top button
CATAMARCA NEWS